Expressions of IGF-1R and IGFBP3 in Advanced Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Kim, Y. H. [1 ]
Sumiyoshi, S. [1 ]
Hashimoto, S. [1 ]
Masago, K. [1 ]
Togashi, Y. [1 ]
Sakamori, Y. [1 ]
Okuda, C. [1 ]
Mio, T. [1 ]
Mishima, M. [1 ]
机构：
[1] Kyoto Univ Hosp, Kyoto 606, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72455-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S636 / S636
页数：1
相关论文
共 50 条
  • [31] IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer
    Al-Zahrani, A
    Sandhu, MS
    Luben, RN
    Thompson, D
    Baynes, C
    Pooley, KA
    Luccarini, C
    Munday, H
    Perkins, B
    Smith, P
    Pharoah, PDP
    Wareham, NJ
    Easton, DF
    Ponder, BAJ
    Dunning, AM
    HUMAN MOLECULAR GENETICS, 2006, 15 (01) : 1 - 10
  • [32] IGF-1R IS A PREDICTIVE BIOMARKER FOR EGFR TKI (GEFITINIB) RESISTANCE IN NON-SMALL CELL LUNG CANCER USING IHC AND AQUA TECHNOLOGY
    Kato, Yasufumi
    Wynes, Murry W.
    Mascaux, Celine
    Asuncion, Bernadette G. Reyna
    Cindy Tran
    Yoshida, Koichi
    Matsubayashi, Jun
    Ohira, Tatsuo
    Furukawa, Kinya
    Nagao, Toshitaka
    Ikeda, Norihiko
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S449 - S450
  • [33] An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer
    Zheng, Xianan
    Lu, Guohua
    Yao, Yinan
    Gu, Wei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (09): : 1882 - 1891
  • [34] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [35] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [36] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [37] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [38] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [39] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
12345